Outcomes From Real-World Data on Intraoperative Electronic Radiotherapy for the Treatment of Early-Stage Breast Cancer: Long-Term Recurrence and Survival Outcomes From a Single Center

被引:0
|
作者
de la Mata, Dolores [1 ]
Santiago-Concha, Bernardino Gabriel [1 ]
Bargallo-Rocha, Juan Enrique [2 ]
Robles-Vidal, Carlos Daniel [2 ]
Gomez-Pue, Daniella [2 ]
Castorena-Roji, Gerardo [2 ]
Hinojosa-Gomez, Jose [1 ]
Flores-Vazquez, Fabiola [1 ]
Blake-Cerda, Monika [1 ]
Enriquez-Barrera, Mario [1 ]
Maffuz-Aziz, Antonio [2 ]
机构
[1] Ctr Med ABC, Dept Radiat Oncol, Mexico City, Mexico
[2] Ctr Med ABC, Dept Oncol Surg Gynecol Surg, Mexico City, Mexico
关键词
IORT; Lumpectomy; Mastectomy-free; Overall survival; Targeted radiotherapy; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; IRRADIATION; LUMPECTOMY; MASTECTOMY; TRIAL; ELIOT; NODE;
D O I
10.1155/2024/6207762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study is aimed at investigating the 10-year outcomes of intraoperative radiotherapy (IORT) in Mexican women with early breast cancer (EBC) treated at the Centro Medico ABC, Mexico City.Methods: A cohort study included women with early-stage invasive ductal carcinoma aged >= 45 years without prior oncologic treatment, tumor size <= 3.5 cm, cN0M0, positive hormone receptors, margins >= 2 mm, negative sentinel lymph nodes, and no extensive lymphovascular invasion. IORT was administered at 20 Gy for 20-30 min after a lumpectomy. Follow-up extended over 10 years and included clinical examinations every 6 months for the first 18 months, followed by annual mammograms and conventional examinations. Patients out of the criteria were excluded from this study because they were referred for additional surgery and/or whole-breast radiation therapy.Results: The study involved 238 patients with an average age of 61.1 years. The mean tumor size was 12 mm, and the percentages of lymphatic invasion, positive hormone receptors, and HER2/neu overexpression were 12.6%, 90.8%, and 2.1%, respectively. The median follow-up was 66.6 months (range: 1-126 months), and the overall survival and mastectomy-free rate reached 95.7% and 90%, respectively. Thirteen patients showed side effects; four recurrences were recorded, of which 50% were out-field relapses. The 5-year Kaplan-Meier probability of local relapses, mastectomy-free, and overall survival reached 97.5%, 100%, and 98%, respectively.Conclusions: This is the first 10-year report about the effect of IORT on Mexican women with EBC in the early stages. Strict adherence to the selection criteria in this study resulted in low rates of side effects, mortality, and local recurrences, demonstrating that IORT is an effective treatment alternative for patients with EBC. Studies with a longer follow-up period should be performed, as recurrences can occur in the long term.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Long-term outcomes of intraoperative radiotherapy for early-stage breast cancer in China: a multicenter real-world study
    Wang, Xin
    Feng, Kexin
    Wang, Wenyan
    Meng, Xiangzhi
    Liu, Jiaqi
    Yang, Yang
    Zhong, Yuting
    Li, Jingruo
    Wu, Shikai
    Li, Minghui
    Ma, Pan
    Feng, Qinfu
    Zeng, Hongmei
    Gu, Yuanting
    Li, Xiru
    Fan, Zhaoqing
    Wang, Xiang
    CANCER COMMUNICATIONS, 2022, 42 (03) : 277 - 280
  • [2] Patient Characteristics, Treatment and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High risk of Recurrence in Scotland
    Hall, P. S.
    Tramonti, G.
    Ranopa, M.
    Vallet, M.
    Jarvis, R.
    Badreldin, W.
    BREAST, 2023, 68 : S21 - S22
  • [3] Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program
    Rana, Shushan
    Naik, Arpana
    Pillai, Susha
    Vetto, John
    Pommier, Rodney
    Kubicky, Charlotte Dai
    AMERICAN JOURNAL OF SURGERY, 2020, 219 (04): : 655 - 659
  • [5] Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.
    Dogan, Izzet
    Aydin, Esra
    Paksoy, Nail
    Ferhatoglu, Ferhat
    Ak, Naziye
    Ibis, Kamuran
    Onder, Semen
    Tukenmez, Mustafa
    Cabioglu, Neslihan
    Muslumanoglu, Mahmut
    Saip, Pinar
    Aydiner, Adnan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Evaluation of Treatment Outcomes of Early-Stage Endometrial Cancer Radiotherapy: A Single Center Experience
    Demiral, S.
    Beyzadeoglu, M.
    Sager, O.
    Dincoglan, F.
    Uysal, B.
    Gamsiz, H.
    Akin, M.
    Turker, T.
    Dirican, B.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9599 - 9602
  • [7] Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
    Brooks, Eric D.
    Sun, Bing
    Feng, Lei
    Verma, Vivek
    Zhao, Lina
    Gomez, Daniel R.
    Liao, Zhongxing
    Jeter, Melenda
    O'Reilly, Michael
    Welsh, James W.
    Quynh-Nhu Nguyen
    Erasmus, Jeremy J.
    Eapen, George
    Ahrar, Kamran
    Antonoff, Mara B.
    Hahn, Stephen M.
    Heymach, John, V
    Rice, David C.
    Chang, Joe Y.
    JAMA NETWORK OPEN, 2018, 1 (04)
  • [8] Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial
    Orecchia, Roberto
    Veronesi, Umberto
    Maisonneuve, Patrick
    Galimberti, Viviana Enrica
    Lazzari, Roberta
    Veronesi, Paolo
    Jereczek-Fossa, Barbara Alicja
    Cattani, Federica
    Sangalli, Claudia
    Luini, Alberto
    Caldarella, Pietro
    Venturino, Marco
    Sances, Daniele
    Zurrida, Stefano
    Viale, Giuseppe
    Leonardi, Maria Cristina
    Intra, Mattia
    LANCET ONCOLOGY, 2021, 22 (05): : 597 - 608
  • [9] Real-world outcomes of neoadjuvant treatment for HER2 positive early-stage breast cancer.
    Naik, Hiten
    Gelmon, Karen A.
    Gondara, Lovedeep
    Diocee, Rekha M.
    Speers, Caroline
    Yerushalmi, Rinat
    Lohrisch, Caroline A.
    LeVasseur, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer
    Haiderali, Amin
    Rhodes, Whitney C.
    Gautam, Santosh
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (29) : 3819 - 3831